Advertisement
Stelis Biopharma
Premium
Healthcare
16 October, 2024
Swiss investor HBM leads funding in TPG-backed drugmaker at $1.65 bn valuation
Swiss investment firm HBM Healthcare has led a Rs 801 crore ($95 million) funding round in an Indian contract drug ......
Premium
Healthcare
25 September, 2023
TPG-backed firm to absorb Indian drugmaker's contract development biz, go public
An Indian biopharmaceutical company that counts private equity firm TPG as an investor will absorb a local drugmaker’s contract development ......
Healthcare
05 July, 2023
GIC-backed Syngene inks $88-mn deal to buy Stelis Biopharma's unit
Syngene International Ltd, a drug research company backed by Singapore sovereign wealth fund GIC, is set to acquire Stelis Biopharma’s manufacturing unit in Bengaluru for ......
Premium
Finance
18 May, 2021
Virus hits mid-stage funding volumes even as investors boast bigger cheques
Mid-stage dealmaking volumes fell in virus-hit years even as investors sent out bigger cheques for Series B and C rounds, ......
Advertisement
Most Popular
Advertisement
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News